You may recognize his name from his younger days as a professional wrestler in the WWE — Bret (The Hitman) Hart, as he was and still is known, was a five-time WWE World Heavyweight Champion who may be facing one of his toughest battles yet.
A survivor at heart, Hart in recent days announced his diagnosis and fight against prostate cancer, and said he had undergone surgery to rid himself of the disease.
It is unclear how long Hart has been fighting prostate cancer, but it is our hope that his openness about his diagnosis and treatment will help other men facing the same silent killer.
Hart said, “I refuse to lose, I will never give in or give up, and I will win this battle or die trying. Most important of all, I hope I can take the fight to prostate cancer. To be a leader in awareness and to set the example for men everywhere who find themselves in my very same shoes, that prostate cancer can be beaten.”
He is a true inspiration to all men facing the challenges of prostate cancer diagnosis and treatment.
This is not the 58-year-old’s first serious health battle, having had a stroke in the early 2000’s. The Hitman retired from a successful career in wrestling after suffering a concussion in 1999.
But the pro wrestling Hall of Famer calls his battle with prostate cancer his “toughest battle” yet.
We commend Hart for the strength he is showing by sharing his battle against prostate cancer with the world. In an emotional Facebook post, Hart wrote, “I make a solemn vow to all of those that once believed in me, the dead and the living, that I will wage my fearsome fight against cancer with one shield and one sword carrying my determination and my fury for life, emboldened by all the love that’s kept me going this long already.”
Tens of thousands of additional men suffer from the burden of painful metastatic prostate cancer, which can lead to bone fractures, the inability to urinate, spinal cord compression and renal failure.
Since the widespread adoption of PSA screening in the early 1990’s, however, there has been a 39% reduction in prostate cancer mortality rates.
For most men, prostate cancer isn’t a concern until after the age of 55. And while the majority of prostate cancer diagnoses occur amid that age group, prostate cancer does get diagnosed in men much younger than that.
Current governmental guidelines may give a false sense of security in younger men who are quick to believe prostate cancer is an “old man’s disease.” The truth is, prostate cancer can strike at any age. It does not discriminate, and early detection is our best defense against this silent killer.
Early detection happens through screening and the PSA (prostate specific antigen) blood test. Prostate cancer is a mostly asymptomatic disease, so if we tell men not to get screened we’re essentially saying, “Yes, you may verywell get prostate cancer and, yes, it might become painfully metastatic, but wouldn’t it just be easier not knowing?”
Because PSA tests are not necessarily straightforward, simple or easy diagnostic tools, knowing your risk factors and tracking the changes in PSA can help you make informed decisions about your health.
Until we get improved diagnostic testing, younger men need to be encouraged to understand their risk factors when it comes to prostate cancer, and get screened.
High-risk men include, but are not limited to, those of African American descent and men with a family history of prostate cancer. These groups should begin screening at age 40, followed by annual tests.
Knowledge really is power in the fight against this form of cancer. By spreading the word, we are doing our part in reducing the number of men who need to lose their lives to prostate cancer. Key facts about prostate cancer:
The best way to prevent prostate cancer is by being proactive about your health. Here’s how:
If you are diagnosed with prostate cancer, talk to a specialist about treatment options to determine which type is best for your cancer and when to have it done. Listen to your doctor; do not procrastinate. If appropriate, a robotic prostatectomy is often the most successful form of treatment.
Dr. Samadi is a board-certified urologic oncologist trained in open and traditional and laparoscopic surgery, and an expert in robotic prostate surgery. He is chairman of urology, chief of robotic surgery at Lenox Hill Hospital and professor of urology at Hofstra North Shore-LIJ School of Medicine. He is a medical correspondent for the Fox News Channel’s Medical A-Team and the chief medical correspondent for am970 in New York City, where he is heard Sundays at 10 a.m. Learn more at roboticoncology.com and SamadiMD.com. Follow Dr. Samadi on Twitter and Facebook.Health articles